Peter Kampian, a newly appointed director of Greenlane Holdings, Inc., filed an initial statement of beneficial ownership with the SEC on November 9, 2026, reporting no securities beneficially owned as of the event date of October 27, 2026.
Kyle Clark, an officer of BETA Technologies, Inc., filed a Form 144 notice of proposed sale on November 9, 2026, disclosing plans to sell 10,000 shares of common stock on the NYSE under Rule 144 of the Securities Act of 1933.
Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), filed a Form 4 on November 9, 2026, disclosing the sale of 53,389 shares of common stock on November 5, 2026, to cover tax withholding obligations related to vesting restricted stock units.
Teva Pharmaceutical Industries Ltd's Executive Vice President of European Commercial, Richard Daniell, filed a Form 144 notice of proposed sale of 25,000 ordinary shares on November 9, 2026, with the sale to be executed through Citigroup Global Markets Inc. on NYSE.
Gartner, Inc. officer Yvonne Genovese filed a Form 144 notice of proposed sale of 524 shares of Gartner common stock, submitted on November 9, 2026.
Awilhelmsen AS, listed as a director-related entity of Royal Caribbean Cruises Ltd, filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 500,000 shares of Royal Caribbean common stock on the NYSE.
Accel Entertainment, Inc. Chief Strategy Officer Steven W. Arntzen filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 10,000 shares of common stock through UBS Financial Services, Inc.
Former Ball Corporation officer Kathleen E. Pitre filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 30,245 shares of Ball Corporation common stock with an aggregate market value of $2,037,705.46.
Mohawk Industries, Inc. officer Mauro Vandini filed a Form 144 notice of proposed sale of securities with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing an intent to sell 5,000 shares of Mohawk Industries common stock on the NYSE.
Rashida La Lande, Executive Vice President and General Counsel of Estee Lauder Companies Inc., filed a Form 4 on November 9, 2026, disclosing the exercise of stock options and the subsequent sale of all resulting Class A Common Stock shares on the same date.